Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 7971-7980 Newer>

Pharmaceutical Executive October 1, 2011 William Looney	Pathfinder in Primary Care Few clinicians have been as central to the development of treatments that demonstrate the value of medicines in advancing public health as Dr. Antonio Gotto.
Pharmaceutical Executive October 1, 2011	The Essential--and Effective--Bureaucrat Fernand Sauer, First Director General, European Medicines Agency, has witnessed the progressive sterilization of innovative research due to a trend toward ever-larger industry concentration.
Pharmaceutical Executive October 1, 2011 Jennifer Ringler	The "Mother" of Invention Abbey Meyers, Founder, National Organization of Rare Disorders, believes patient empowerment can foster change.
Pharmaceutical Executive October 1, 2011 William Looney	The Crisis Manager Peter Piot continues his dual role as Director of the London School of Hygiene and Tropical Medicine, where he promotes systemwide innovations in public health while applying his deep knowledge of the HIV environment to raise the visibility of non-communicable diseases on the global policy agenda.
Pharmaceutical Executive October 1, 2011 Jill Wechsler	Guiding a Revolution in Science Francis Collins led the genomic revolution as director of the International Human Genome Project and director of the National Human Genome Research Institute (NHGRI) at the NIH from 1993 to 2008.
Pharmaceutical Executive October 1, 2011	The Legacy of High Expectations Andrew Witty, Chairman & CEO, GlaxoSmithKline, believes the pharmaceutical industry will continue to make a significant contribution to society if it continues to improve the way it goes about its work.
Pharmaceutical Executive October 1, 2011 Ansis Helmanis	IP: Securing a Global Consensus--Can Industry Do It Again? Dr. Harvey Bale's long career in defense of IP took him from service as Assistant US Trade Representative to high-profile industry association posts.
Pharmaceutical Executive October 1, 2011 Ansis Helmanis	Lessons from the FDA Front Line Is the research-based industry less productive today than 30 years ago? To former Commissioner Jane Henney, the answer is straightforward.
Pharmaceutical Executive October 1, 2011 William Looney	Bravura Performer As chief executive of a trim, mid-size pharma player with a distinctive portfolio franchise, Angus Russell has made his reputation as an iconoclast -- the antagonist of bloat.
Pharmaceutical Executive October 1, 2011	Physicians: Still the Vital Connection in Medicine Jean-Claude Labrune, Chairman; CEO, Cegedim Group reflects on his career.
<Older 7971-7980 Newer> Return to current articles.